Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - compresse - carbamazepinum 200 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - compresse - carbamazepinum 400 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - compresse - carbamazepinum 100 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - sospensione orale - carbamazepinum 100 mg, macrogoli 8 stearas typus i, hydroxyethylcellulosum, cellulosum microcristallinum, carmellosum natricum, sorbitolum liquidum non cristallisabile 1.25 g, propylenglycolum 125 mg, aqua purificata, aromatica (caramel), saccharinum natricum, e 200, propylis parahydroxybenzoas 1.5 mg, e 218 6 mg ad suspensionem pro 5 ml corresp. natrium 0.57 mg. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - retardtabletten - carbamazepinum 400 mg, magnesii stearas, silica colloidalis anhydrica, ethylcellulosum, talcum, polyacrylatis dispersio 30 per centum, carmellosum natricum conexum corresp. natrium 3 mg, cellulosum microcristallinum, Überzug: macrogolglyceroli hydroxystearas 0.44 mg, talcum, hypromellosum, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - retardtabletten - carbamazepinum 200 mg, magnesii stearas, silica colloidalis anhydrica, ethylcellulosum, talcum, polyacrylatis dispersio 30 per centum, carmellosum natricum conexum corresp. natrium 2 mg, cellulosum microcristallinum, Überzug: macrogolglyceroli hydroxystearas 0.22 mg, talcum, hypromellosum, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - oxcarbazepinum - sospensione orale - oxcarbazepinum 60 mg, aqua purificata, sorbitolum liquidum non cristallisabile 250 mg, propylenglycolum 25 mg, cellulosum dispergibile, macrogoli 8 stearas typus i, aromatica, saccharinum natricum, e 300, e 200, propylis parahydroxybenzoas 0.3 mg, e 218 1.2 mg ad suspensionem pro 1 ml corresp. natrium < 23 mg. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - oxcarbazepinum - compresse rivestite con film - oxcarbazepinum 150 mg, silica colloidalis anhydrica, crospovidonum, hypromellosum, magnesii stearas, cellulosum microcristallinum, Überzug: macrogolum 4000, talcum, hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - oxcarbazepinum - compresse rivestite con film - oxcarbazepinum 600 mg, silica colloidalis anhydrica, crospovidonum, hypromellosum, magnesii stearas, cellulosum microcristallinum, Überzug: macrogolum 4000, talcum, hypromellosum, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepilepticum - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - carbamazepinum - compresse - carbamazepinum 200 mg, excipiens pro driver. - antiepileptikum - synthetika